Dubious doctrines: The quasi-class action

University of Cincinnati Law Review

Volumn 80, Issue 2, 2011, Pages 389-429

  Mullenix, Linda S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867227940     PISSN: 00096881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Fla. Power Corp. v. Granlund, 82 F.R.D. 690,692 (M.D. Fla. 1979).
2. Charles Silver & Geoffrey P. Miller, The Quasi-Class Action Method of Managing Multi-District Litigations: Problems and a Proposal, 63 Vand. L. Rev. 107, 116 (2010)
3. Shaffer v. Heitner, 433 U.S. 186 (1977).
4. Fed. R. Civ. P. 23
5. Amchem Prods. Inc. v. Windsor, 521 U.S. 591 (1997).
6. Ortiz v. Fibreboard Corp., 527 U.S. 815 (1999).
7. THE PRINCIPLES OF THE LAW OF AGGREGATE LITIGATION § 3 (2010).
8. 28 U.S.C. § 1407 (2006).
9. Zyprexa Prods. Liab. Litig., 233 F.R.D. 122 (E.D.N.Y. 2006)
10. McMillan v. City of New York, No. 08-CV-2887, 2010 WL 1487738, at 1 (E.D.N.Y. Apr. 13, 2010)
11. McMillan v. City of New York, No. CV 08 2887
12. McMillan v. City of New York, No. 03-CV-6049, 2008 WL 4287573 at 5.
13. New Jersey Inc. v. Philip Morris, Inc., 133 F. Supp. 2d 162, 178
14. United States v. Cheung, 952 F. Supp. 148, 148-49) (E.D.N.Y. 1997)
15. Fair Labor Standards Act, 29 U.S.C. §§ 201 to 219 (2006) [hereinafter FLSA].
16. 29 U.S.C.A. § 216(b) (West 2008).
17. Abubakar v. City of Solano, No. CIV S-06-2268 LKK EFB.
18. Douglas v. GE Energy Reuter Stokes, No. 1:07CV077, 2007 WL 1341779 at 3 (N.D. Ohio Apr. 30, 2007)
19. Highland v. Wal-Mart Stores, Inc., No. CIV04-0711, 2005 WL 3415855 at 1, n.l (D.N.M. Sept. 15,2005)
20. Montalto v. Morgan Guar. Trust Co., 83 F.R.D. 150, 152 (S.D.N.Y. 1979).
21. Douglas, 2007 WL 1341779 at 3
22. Highland, 2005 WL 3415855 at 1, n.1
23. Hallas v. Western Electric Co., Inc., No. C-2-79-519, 1981
24. Cowlishaw v. Armstrong Rubber Co., 425 F. Supp. 802, 806 (E.D.N.Y. 1977)
25. Swettman v. Remington Rand, 65 F. Supp. 940,944 (S.D. 111. 1946).
26. McFarland v. State Farm Fire & Cas. Co., No. CIVA1:06CV466LTS-RHW, 2006 WL 3071988, at 2 (S.D. Miss. Oct. 25, 2006)
27. McFarland v. State Farm Fire & Cas. Co., No. 1:06CV466-LTS-RHW, 2006 WL 2577852, at 2
28. Vaz v. Allstate Property & Cas. Co., No. 1:06CV48I LTS RHW, 2006 WL 2583733, at 2 (S.D. Miss. Sept. 6, 2006)
29. Bradley v. Nationwide Mut. Ins. Co., No. 1:06CV528-LTS-RHW, 2006 WL 2594548, at 2 (S.D. Miss. Sept. 6, 2006)
30. Guice v. State Farm Fire & Cas. Co., No. 1:06CV1 -LTS-RHW, 2006 WL 2359474 (S.D. Miss. Aug. 14, 2006)
31. McFarland, 2006 WL 2577852, at 1.
32. McFarland, 2006 WL 3071988, at 2.
33. Avila v. Willits Env't, No. C 99-03941 SI.
34. United States v. Gallion, 257 F.R.D. 141, 158 (E.D. Ky. 2009)
35. Gordon and Breach Sci. Publishers S.A. v. Am. Inst. Physics, 905 F. Supp. 169, 179 n.9 (S.D.N.Y. 1995)
36. Joseph v. Hage, 121 B.R. 679, 682.
37. Fla. Power Corp. v. Granlund, 82 F.R.D. 690, 694 (M.D. Fla. 1979)
38. EEOC v. Rexene Polymers Co., MO-74-CA-62, 1975 WL 121 (W.D. Tex. 1975)
39. City of New York v. Smokes Spirits.com, Inc., 541 F.3d 425, 44 n.24
40. In re Zyprexa Prods. Liab. Litig., 239 F.R.D. 316 (E.D.N.Y. 2007)
41. In re Zyprexa Prods. Liab. Litig., 239 F.R.D. 316.
42. FED. R. CIV. P. 23(h).
43. Manual for Complex Litigation § 14 (4th ed. 2004).
44. In re Zyprexa Prods. Liab. Litig., 233 F.R.D. 122 (E.D.N.Y. 2006)
45. In re Zyprexa Prods. Liab. Litig., No. 04 MD 1596, 2008
46. In re Zyprexa Prods. Liab. Litig., 233 F.R.D. at 122.
47. In re Zyprexa Prods. Liab. Litig., No. 04-MD-1596, 2009 WL 5062109
48. In re Zyprexa Prods. Liab. Litig., 260 F.R.D. 13 (E.D.N.Y. 2009)
49. In re Zyprexa Prods. Liab. Litig., No. 04-MD-1596, 2009 WL 1173069, at app. A (E.D.N.Y. May 1, 2009)
50. In re Zyprexa Prods. Liab. Litig., 253 F.R.D. 69 (E.D.N.Y. 2008)
51. In re Zyprexa Prods. Liab. Litig., No. 04-MD-1596, 2008 WL 2696916 (E.D.N.Y. July 2, 2008)
52. In re Zyprexa Prods. Liab. Litig., 451 F. Supp. 2d 458 (E.D.N.Y. 2006)
53. In re Zyprexa Prods. Liab. Litig., No. 04 MD 1596 (JBW), 2009 WL 3597447
54. In re Zyprexa Prods. Liab. Litig., No. 04 MD 1596, 2009 WL 1850970 (E.D.N.Y. June 22, 2009)
55. In re Zyprexa Prods. Liab. Litig., No. 04 MD 1596, 2009 WL 1851062 (E.D.N.Y. June 22, 2009)
56. In re Zyprexa Prods. Liab. Litig., 688 F. Supp. 2d 130 (E.D.N.Y. 2009)
57. In re Zyprexa Prods. Liab. Litig., 238 F.R.D. 539 (E.D.N.Y. 2006)
58. In re Zyprexa Prods. Liab. Litig., 649 F. Supp. 2d 18 (E.D.N.Y. 2009)
59. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596, 06-CV-2798, 2009 WL 2487305
60. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596
61. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW), 06-CV-2782 (JBW), 2009
62. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW), 07-CV-987 (JBW), 2009
63. In re Zyprexa Prods. Liab. Litig.
64. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW)
65. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW)
66. In re Zyprexa Prods. Liab. Litig., 671 F. Supp. 2d 397
67. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW)
68. In re Zyprexa Prods. Liab. Litig., Nos. 04-MD-1596 (JBW)
69. In re Zyprexa Prods. Liab. Litig., 238 F.R.D. 539
70. In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256 (E.D.N.Y. 2006)
71. In re Zyprexa Prods. Liab. Litig., 433 F. Supp. 2d 268 (E.D.N.Y. 2006)
72. In re Zyprexa Prods. Liab. Litig., 424 F. Supp. 2d 488 (E.D.N.Y. 2006)
73. In re Zyprexa Prods. Liab. Litig., 233 F.R.D. 122 (E.D.N.Y. 2006)
74. In re Zyprexa Prods. Liab. Litig., 671 F. Supp. 2d 397.
75. In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d at 262
76. In re Zyprexa Prods. Liab. Litig., 424 F. Supp. 2d at 491.
77. In re Zyprexa Prods. Liab. Litig., 671 F. Supp. 2d at 433
78. In re Zyprexa Prods. Liab. Litig., 238 F.R.D. at 540
79. In re Zyprexa Prods. Liab. Litig., 424 F. Supp. 2d at 491.
80. In re Zyprexa Prods. Liab. Litig., 233 F.R.D. at 122
81. In re Zyprexa Prods. Liab. Litig., 433 F. Supp. 2d 268, 271 (E.D.N.Y. 2006)
82. In re Zyprexa Prods. Liab. Litig., 433 F. Supp. 2d at 271.
83. In re Zyprexa Prods. Liab. Litig., 233 F.R.D. 122, 122 (E.D.N.Y. 2006).
84. In re Zyprexa Prods. Liab. Litig., 424 F. Supp. 2d at 491
85. Class Action Fairness Act of 2005, Pub. L. No. 109-2, § 5, 119 Stat. 4 (2005)
86. In re Zyprexa Prods. Liab. Litig., 424 F. Supp. 2d at 491.
87. In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256, 269 (E.D.N.Y. 2006)
88. In re Zyprexa Prods. Liab. Litig., 433 F. Supp. 2d 268, 271 (E.D.N.Y. 2006)
89. Amchem Prods., Inc. v. Windsor, 521 U.S. 591 (1997).
90. Ortiz v. Fibreboard Corp., 527 U.S. 815 (1999).
91. Stephenson v. Dow Chemical Co., 273 F.3d 249 (2d Cir. 2001)
92. Re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d at 269
93. Re Zyprex Prods. Liab. Litig., 238 F.R.D. 539, 541 (E.D.N.Y. 2006)
94. Stephenson v. Dow Chemical Co., 273 F.3d 249
95. Re Zyprexa Prods. Liab. Litig., 433 F. Supp. 2d 268, 271
96. Re Zyprex Prods. Liab. Litig., 238 F.R.D. at 541.
97. Petition for Writ of Certiorari, In re: Vioxx Prods. Liab. Litig., 2010 U.S. Briefs 666 (Nov. 17, 2010) (No. 10-666)
98. Re Vioxx Prods. Liab. Litig., 360 F. Supp. 2d 1352 (J.P.M.L. 2005)
99. Re Vioxx Prods. Liab. Litig., 239 F.R.D. 450,458-59,461 (E.D. La. 2006)
100. In re Vioxx Prods. Liab. Litig., 650 F. Supp. 2d at 552.
101. http://www.browngreer.com/vioxxsettlement.
102. In re Vioxx Prods. Liab. Litig., No. 09-30446,388 Fed. App'x 391,393 (5th Cir. 2010)
103. In re Vioxx Prods. Liab. Litig., 650 F. Supp. 2d at 552-53
104. In re Vioxx Prods. Liab. Litig., No. 08-1633, 2008 WL 3285912
105. In re Vioxx Prods. Liab. Litig., 650 F. Supp. 2d at 553
106. Hansberry v. Lee, 311 U.S. 32 (1940).
107. FED.R.CIV.P.23(a)(4).
108. Fed. R. Civ. P. 23(g).
109. FED.R.CIV.P.23(g)(1).
110. Fed. R. Civ. P. 23(g)(2).
111. FED. R. Crv. P. 23(a)(1)-C)
112. FED.R.CIV.P.23(b)(1)3
113. Amchem Prods, v. Windsor, 521 U.S. 591, 594 (1997)
114. FED. R. Crv. P. 23(c).
115. FED. R. Crv. P. 23(e).
116. Hilao v. Estate of Marcos, 103 F.3d 767 (9th Cir. 1996)
117. Jenkins v. Raymark Indus., Inc., 782 F.2d 468 (5th Cir. 1986)
118. Castano v. Am. Tobacco Co., 84 F.3d 734 (5th Cir. 1996)
119. In re Am. Med. Sys., Inc., 75 F.3d 1069 (6th Cir. 1996)
120. Class Action Fairness Act of 2005, Pub. L. No. 109-2, § 5, 119 Stat. 4 (2005).
121. 28 U.S.C. § 1453 (2006)
122. Amchem Prods, Inc. v. Windsor, 521 U.S. 591 (1997).
123. Ortiz v. Fibreboard Corp., 527 U.S. 815 (1999).
124. MANUAL FOR COMPLEX LITIGATION (FOURTH) § 22.33 (2004)
125. Georgine v. Amchem Prods., Inc., 83 F.3d 610 (3d Cir. 1996)
126. Georgine v. Amchem Prods. Inc., 157 F.R.D. 246 (E.D. Pa. 1994)
127. In re Inter-Op Hip Prosthesis Liab. Litig., 204 F.R.D. 330
128. In re Diet Drugs Prods. Liab. Litig., Nos. 1203, 99-20593, 2000 WL 1222042
129. 28 U.S.C. § 1407(e)
130. 28 U.S.C. § 1407(a).
131. 28 U.S.C. § 1407(b)
132. Susan P. Koniak, Feasting While the Widow Weeps: Georgine v. Amchem Products, Inc., 80 CORNELL L. REV. 1045 (1995)
133. Roger C. Cramton, Individualized Justice, Mass Torts, And "Settlement Class Actions": An Introduction, 80 CORNELL L. REV. 811 (1995)
134. Air Transportation Safety and System Stabilization Act, IV, Pub. L. No. 107-42, 115 Stat. 230 (2001)
135. U.S.C. § 40101 (2006)
136. Kenneth R. Feinberg et al., FINAL REPORT OF The Special Master for the September 11th Victim Compensation Fund of 2001 (2004)
137. http://www.usdoj.gov/final-report.pdf.
138. Kenneth Feinberg, Transparency and Civil Justice: The Internal and External Value of Sunlight, 58 DePaul L. Rev. 473,476. (2009)
139. PRINCIPLES OF AGGREGATE LITIGATION ch. 3 (2010).